Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression

Blood

Volumn 93, Issue 8, 1999, Pages 2721-2729

  Rots, Nynke Y ^a   Iavarone, Antonio ^a   Bromleigh, Virginia ^a   Freedman, Leonard P ^a,b  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLINE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033561445     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2721.408k28_2721_2729     Document Type: Article

References (29)

1. Sherr C: Mammalian G1 cyclins. Cell 73:1059, 1993
2. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149, 1995
3. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
4. El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
5. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
6. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90, 1994
7. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67, 1994
8. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59, 1994
9. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639, 1995
10. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704, 1993
11. Guan K-L, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by p18, a p16INK4/MTS1 and p14INK4/MTS2-related CDK6 inhibitor, correlates with wildtype Rb function. Genes Dev 8:2939, 1994
12. Hirai H, Roussel MF, Kato J-Y, Ashmun RA, Sherr CJ: Novel Ink4 proteins, p19 and p18, are specific inhibitors of the cylcin-dependent kinases CDK4 and CDK6. Mol Cell Biol 11:1185, 1995
13. Chan FKM, Zhang J, Cheng L, Shapiro DN, Winoto A: Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to to p16INK4. Mol Cell Biol 15:2682, 1995
14. Zeng Y-X, El-Deiry WS: Regulaton of p21/Waf1/Cip1 expression by p53-independent pathways. Oncogene 12:1557, 1996
15. Polyak K, Kato J-y, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cylce arrest. Genes Dev 8:9, 1994
16. Reynisdottir I, Polyak K, Iavarone A, Massague J: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831, 1995
17. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018, 1995
18. Liu M, Iavarone A, Freedman LP: Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 271:31723, 1996
19. Rogatsky I, Trowbridge JM, Garabedian MJ: Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 17:3181, 1997
20. Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler HG, Firestone GL: Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells J Biol Chem 273:1998, 1998
21. Chin YE, Kitagawa M, Su, W-CS, You Z-H, Iwamoto Y, Fu X-Y: Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIp1 mediated by STAT1. Science 272:719, 1996
22. Liu M, Lee M-H, Cohen M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
23. Rots NY, Liu M, Anderson EC, Freedman LP: A differential screen for ligand-regulated genes: Identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells. Mol Cell Biol 18:1911, 1998
24. Ollson I, Gullberg U, Ivhed I, Nillson K: Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1,25-dihydroxycholcalciferol. Cancer Res 43:5862, 1983
25. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750, 1994
26. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847, 1997
27. Meyyappan M, Wong H, Hull C, Riabowol KT: Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol Cell Biol 18:3163, 1998
28. Mantel C, Luo Z, Canfield J, Braun S, Deng C, Broxmeyer HE: Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88:3710, 1996
29. Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK, Dotto GP: Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280: 1069, 1998